MoneyWorks4Me

Marksans Pharma informs about board meeting

08 May 2025 Evaluate
Marksans Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025, to consider and approve the Audited Financial Results of the Company (both Standalone and Consolidated) for the Quarter and Year ended March 31, 2025; To consider recommendation of dividend on the equity shares for the financial year 2024-25, if any.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..